Curcumin-Loaded Macrophage-Derived Exosomes Effectively Improve Wound Healing

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Wound Healing Research

Background:

• Diabetic wounds present a significant clinical challenge due to impaired healing processes.
• Exosomes offer a promising cell-free therapeutic approach for tissue regeneration.
• Curcumin exhibits anti-inflammatory and antioxidant properties beneficial for wound repair.

Purpose of the Study:

• To evaluate the therapeutic efficacy of curcumin-loaded macrophage-derived exosomes (Exos-cur) in accelerating diabetic wound healing.
• To investigate the underlying mechanisms of Exos-cur in promoting wound repair, including anti-inflammation and angiogenesis.

Main Methods:

• In vitro studies using human umbilical vein endothelial cells (HUVECs) to assess proliferation, migration, angiogenesis, and oxidative stress.
• In vivo experiments on diabetic rats with skin defects to evaluate wound closure, contraction, and tissue regeneration.
• Histological analyses (HE and Masson staining) and molecular analyses (Western blot, immunofluorescence) to examine cellular and molecular changes.

Main Results:

• Exos-cur promoted HUVEC proliferation, migration, and angiogenesis while reducing reactive oxygen species (ROS) and oxidative damage in vitro.
• In vivo, Exos-cur significantly increased wound closure and contraction in diabetic rats.
• Histological examination revealed enhanced re-epithelialization, mature granulation tissue formation, increased vascularization, and collagen deposition in Exos-cur treated wounds.
• Exos-cur activated the Nrf2/ARE pathway, inhibited inflammation, and upregulated pro-angiogenic and wound healing-related molecules.

Conclusions:

• Exosomes derived from curcumin-loaded macrophages (Exos-cur) demonstrate significant therapeutic potential for accelerating diabetic wound healing.
• Exos-cur exerts its effects by reducing oxidative stress and inflammation and promoting angiogenesis through the Nrf2/ARE pathway.
• These findings provide a strong basis for the clinical application of Exos-cur in treating diabetic skin defects.